Author Affiliations
- T Robak,
- JZ Blonski,
- M Kasznicki,
- J Gora-Tybor,
- A Dmoszynska and
- A Skotnicki
Abstract
We present the long-term follow-up and results of subsequent treatments in patients with chronic lymphocytic leukemia treated initially with cladribine + prednisone or chlorambucil + prednisone in a randomized, cross-over study. We found higher complete and overall responses rates in patients who received cladribine + prednisone as first and second-line treatment but no significant differences in survival.